Skip to menu Skip to content Skip to footer

2013

Conference Publication

Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects

Chen, A. C., Martin, M. M., Burr, L., Hasnain, S. Z., Lourie, R., Bowler, S. D., McGuckin, M. A. and Serisier, D. J. (2013). Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects. American Thoracic Society 2013 International Conference, Philadelphia, PA, United States, 17-22 May 2013. New York, United States: American Thoracic Society.

Clinical Benefits Of Long-Term, Low-Dose Erythromycin In Bronchiectasis Are Not Due To Anti-Inflammatory Effects

2012

Journal Article

An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis

Burr, Lucy, Fanning, Steven, Wong, David and Bowler, Simon (2012). An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis. BMJ Case Reports, 2012 (jul02 1), 1-4. doi: 10.1136/bcr-03-2012-5980

An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis